Rare diseases
Investigational molecules
Locations
Back to Italy33 clinical trials in L'aquila, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Atogepant for Treating Migraine in Patients: Evaluating Effectiveness and Safety
ItalyStudy of ritlecitinib (50 mg and 100 mg daily) compared to placebo in adults with nonsegmental vitiligo
ItalyStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
ItalyStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
ItalyStudy on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs
ItalyStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
ItalyA Study of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis Who Did Not Respond Well Enough to Dupilumab Treatment
ItalyStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
ItalyStudy of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
ItalyStudy of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years
ItalyStudy of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes
ItalyStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
ItalyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focus on innovative treatments for atopic dermatitis and prurigo nodularis, evaluating new therapeutic approaches for managing severe skin conditions.
Research emphasizes long-term efficacy and safety of treatments like upadacitinib and amlitelimab.
Studies concentrate on migraine prevention and treatment, including medication overuse headache and innovative approaches using eptinezumab and atogepant.
Trials explore both acute treatment options and preventive therapies for neurological conditions.
Research focuses on treating Sjögren's Syndrome and related autoimmune disorders, evaluating novel therapeutic approaches for systemic manifestations.
Studies aim to improve quality of life for patients with chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
